A Study to Compare the NexGen LPS and LPS-Flex Knee Implants

May 25, 2012 updated by: Zimmer Biomet

Prospective Randomized Multicenter Study of NexGen LPS-Flex Knee

The purpose of this study is to test for significant differences in functional outcomes obtained by using a NexGen LPS versus a NexGen LPS-Flex knee implant. Specifically, it is predicted that an increase in postoperative range of motion will be experienced by patients treated with the NexGen LPS-Flex knee implant.

Study Overview

Detailed Description

This study will compare the clinical results of the NexGen LPS femoral component with the higher flexion potential of the NexGen LPS-Flex femoral component in all patients with degenerative joint disease that require total knee arthroplasty. The primary variable of interest is postoperative range of motion achieved with the two devices, which are implanted with slightly different surgical techniques in patients who may also be subjected to different rehabilitation programs depending on the device they are assigned.

Study Type

Interventional

Enrollment (Actual)

331

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montreal, Quebec, Canada, H4J1C5
        • Hôpital du Sacré-Coeur de Montréal
    • Alabama
      • Birmingham, Alabama, United States, 35294
        • University of Alabama at Birmingham
    • Georgia
      • Decatur, Georgia, United States, 30033
        • VA Medical Center
    • Illinois
      • Springfield, Illinois, United States, 62794
        • Southern Illinois University School of Medicine
    • Indiana
      • Indianapolis, Indiana, United States, 46260
        • Joint Replacement Surgeons of Indiana
      • Mooresville, Indiana, United States, 46158
        • The center for hip and knee surgery
    • North Carolina
      • Charlotte, North Carolina, United States, 28209
        • OrthoCarolina Research Institute
      • Durham, North Carolina, United States, 27710
        • Duke University Medical Center
    • Pennsylvania
      • Allentown, Pennsylvania, United States, 18103
        • VSAS Orthopaedics
      • Philadelphia, Pennsylvania, United States, 19141
        • Albert Einstein Healthcare Network
    • South Carolina
      • Greenville, South Carolina, United States, 29615
        • Piedmont Orthopaedic Associates
      • Spartanburg, South Carolina, United States, 29303
        • Orthopaedic Specialists of Spartanburg
    • Tennessee
      • Nashville, Tennessee, United States, 37232
        • Vanderbilt Orthopaedic Institute
    • Texas
      • Galveston, Texas, United States, 77555
        • Rebecca Sealy Hospital
    • Virginia
      • Charlottesville, Virginia, United States, 22908
        • The Rectors and Visitors of the University of Virginia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age, 21-80 years
  • Sex, Males and females will be included
  • BMI less than or equal to 39 and calf-thigh less than or equal to 90 degrees
  • Stable health, the patient would be able to undergo surgery and participate in the follow-up program based on physical examination and medical history.
  • Patient is willing and able to cooperate in follow-up therapy.
  • Patient exhibits preoperative radiographic evidence of joint degeneration consistent with TKA that cannot be treated in non-operative fashion.
  • Patient has stable and functional collateral ligaments.
  • Patient has potential to perform higher than average range of motion activities.
  • Operative side range of motion flexion greater than or equal to 90 degrees.
  • Severe knee pain and disability due to degenerative joint disease.
  • Patient or patient's legal representative has signed the Informed Consent form.

Exclusion Criteria:

  • Previous history of infection in the affected joint.
  • Previously failed knee endoprosthesis of any kind.
  • Charcot joint disease or other severe neurosensory deficits.
  • Previous patellectomy.
  • Patient is skeletally immature.
  • Grossly insufficient femoral or tibial bone stock.
  • Patient is pregnant.
  • Varus or valgus deformity greater than 20 degrees.
  • Fixed flexion deformity greater than 15 degrees.
  • Previous high tibial osteotomy.
  • Previous femoral osteotomy.
  • Patient is a poor compliance risk - currently treated for ethanol or drug abuse, physical or mental handicap, etc.
  • Loss of musculature or absence of musculoligamentous supporting structures required for adequate soft tissue balance.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 1
Study arm will consist of patients that are treated with the NexGen LPS-Flex Fixed Bearing Knee.
NexGen LPS-Flex Fixed Bearing femoral component
Other Names:
  • LPS-Flex Knee
Active Comparator: 2
Study arm will consist of patients that are treated with the NexGen Legacy Posterior Stabilized Knee.
NexGen Legacy Posterior Stabilized femoral component
Other Names:
  • LPS Knee

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Range of Motion (ROM)
Time Frame: 6 Weeks to 2 Years Post-op, based on on the intervals listed
Postoperative ROM was calculated by taking the measurement of patient flexion minus the measurement of patients' extension.
6 Weeks to 2 Years Post-op, based on on the intervals listed

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Return to Function (RtF) Via Knee Society Score (Modified)
Time Frame: 6 Weeks to 2 Years Post-op, based on on the intervals listed

Scores were calculated from responses on a modified Knee Society Score by the enrolled subjects for the stated visit intervals.

Grading for the Knee Society Score is based on a scale from 0-100 and results are established follows: 80-100 =Excellent; 70-79 = Good; 60-69 = Fair; and Below 60 = Poor.

6 Weeks to 2 Years Post-op, based on on the intervals listed

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2001

Primary Completion (Actual)

December 1, 2009

Study Completion (Actual)

March 1, 2010

Study Registration Dates

First Submitted

September 26, 2008

First Submitted That Met QC Criteria

September 29, 2008

First Posted (Estimate)

September 30, 2008

Study Record Updates

Last Update Posted (Estimate)

June 4, 2012

Last Update Submitted That Met QC Criteria

May 25, 2012

Last Verified

May 1, 2012

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis

Clinical Trials on NexGen LPS-Flex Fixed Bearing Knee

Subscribe